Synthesis and biological evaluation of novel hexahydro-pyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT2C receptor agonists
作者:Hans G.F. Richter、D.R. Adams、A. Benardeau、M.J. Bickerdike、J.M. Bentley、T.J. Blench、I.A. Cliffe、C. Dourish、P. Hebeisen、G.A. Kennett、A.R. Knight、C.S. Malcolm、P. Mattei、A. Misra、J. Mizrahi、N.J.T. Monck、J.-M. Plancher、S. Roever、J.R.A. Roffey、S. Taylor、S.P. Vickers
DOI:10.1016/j.bmcl.2005.11.083
日期:2006.3
optimization efforts on previously described 1,2,3,4,10,10a-hexahydro-1H-pyrazino[1,2-a]indoles led to the new class of 5,5a,6,7,8,9-hexahydro-pyrido[3',2':4,5]pyrrolo[1,2-a]pyrazines culminating in the discovery of (5aR,9R)-2-[(cyclopropylmethoxy)methyl]-5,5a,6,7,8,9-hexahydro-9-methyl-pyrido[3' , 2':4,5]pyrrolo[1,2-a]pyrazine 18 as a potent, full 5-HT(2C) receptor agonist with an outstanding selectivity
对先前描述的1,2,3,4,10,10a-六氢-1H-吡嗪并[1,2-a]吲哚的进一步前导优化工作导致了新的5,5a,6,7,8,9-六氢-吡啶并[3',2':4,5]吡咯并[1,2-a]吡嗪最终导致发现(5aR,9R)-2-[(环丙基甲氧基)甲基] -5,5a,6,7 ,8,9-六氢-9-甲基-吡啶并[3',2':4,5]吡咯并[1,2-a]吡嗪18为有效的全5-HT(2C)受体激动剂,具有出色的选择性轮廓以及出色的hERG和磷脂代谢特性。